David Roblin, CEO of Relation Therapeutics, said: "This financing is a significant milestone for Relation Therapeutics and underscores the confidence our investors have in our innovative approach to ...
Relation announces strategic collaboration with Novartis to advance therapeutics for atopic diseases
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...
GSK has handed over $45 million upfront to fellow London-based firm Relation to help the pharma identify new targets for fibrotic diseases and osteoarthritis. The two-stranded collaboration will see ...
In its second major partnership with a big pharma group, UK-based AI and multi-omics company Relation Therapeutics has agreed to seek out targets for allergic diseases on behalf of Novartis. The ...
WALNUT CREEK, Calif.--(BUSINESS WIRE)--Relation Insurance Services, Inc. (“Relation”) announced today the promotions of Mark Kochner, Josh Bedgood, and Cary Taylor. “Mark, Josh, and Cary have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results